Report Detail
Global Circulating Tumor Cell Diagnostics Market Research Report 2019
- RnM3200592 |
- 28 March, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various tumor markers that can be used along with companion diagnostics to diagnose or monitor various forms of cancer are expected to boost usage rates of CTC tests in the coming years.
Circulating tumor cell detection test possesses the ability to detect, quantify, and analyze tumor cells in the blood of cancer patients. It includes enrichment, detection and analysis of the detected circulating tumor cells. Circulating tumor cells tests are applicable in the characterization of tumor cells through biochemical marker analysis. CTC isolation, detection, and molecular characterization systems find investigational application in prostate, breast, colon, head, neck, skin, lung, and pancreatic cancer
Growing incidences oncology diseases and the introduction of novel biotechnological methods that enable the isolation and quantitation of circulating tumor cells. Furthermore, other factors like early disease diagnosis, cost savings on multiple treatments, drug safety, patient compliance, and optimization of therapies are attributive for rising demand for the preventive medicine, thus influencing the demand for CTC tests.
On course of the forecast period it is expected that over 150 companion diagnostic on-label combinations and a range of personalized therapeutic drugs under clinical trials and development pipelines based on companion diagnostics. The level of adoption of companion diagnostics is expected to significantly increase after these obtain complete FDA approval and are commercialized fully.
The global Circulating Tumor Cell Diagnostics market is valued at 4990 million US$ in 2018 is expected to reach 10100 million US$ by the end of 2025, growing at a CAGR of 9.2% during 2019-2025.
This report focuses on Circulating Tumor Cell Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Circulating Tumor Cell Diagnostics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Janssen Diagnostics
Advanced Cell Diagnostics
Aviva Biosciences
Biocept Inc
Biofluidica Inc.
CellTraffix Inc.
Clearbridge BioMedics Pte Ltd
Epic Sciences Inc.
Fluxion Biosciences Inc.
ScreenCell
Silicon Biosystems
Sysmex Corporation
Greiner Bio-One GmbH
AdnaGen AG
Apocell Inc
Biocep Ltd
Canopus Bioscience Ltd
Creatv Microtech Inc
Ikonisys Inc
IV Diagnostics Inc
Miltenyi Biotech GmbH
Nanostring Technologies Inc
Rarecells Diagnostics.
Vitatex Inc
Segment by Regions
North America
Europe
China
Japan
Segment by Type
CTC Enrichment
CTC Detection
CTC Analysis
Segment by Application
Tumorigenesis research
EMT biomarkers development
Cancer stem cell research
Others
Table of Contents
Executive Summary
1 Circulating Tumor Cell Diagnostics Market Overview
- 1.1 Product Overview and Scope of Circulating Tumor Cell Diagnostics
- 1.2 Circulating Tumor Cell Diagnostics Segment by Type
- 1.2.1 Global Circulating Tumor Cell Diagnostics Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 CTC Enrichment
- 1.2.3 CTC Detection
- 1.2.4 CTC Analysis
- 1.3 Circulating Tumor Cell Diagnostics Segment by Application
- 1.3.1 Circulating Tumor Cell Diagnostics Consumption Comparison by Application (2014-2025)
- 1.3.2 Tumorigenesis research
- 1.3.3 EMT biomarkers development
- 1.3.4 Cancer stem cell research
- 1.3.5 Others
- 1.4 Global Circulating Tumor Cell Diagnostics Market by Region
- 1.4.1 Global Circulating Tumor Cell Diagnostics Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Circulating Tumor Cell Diagnostics Market Size
- 1.5.1 Global Circulating Tumor Cell Diagnostics Revenue (2014-2025)
- 1.5.2 Global Circulating Tumor Cell Diagnostics Production (2014-2025)
2 Global Circulating Tumor Cell Diagnostics Market Competition by Manufacturers
- 2.1 Global Circulating Tumor Cell Diagnostics Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Circulating Tumor Cell Diagnostics Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Circulating Tumor Cell Diagnostics Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Circulating Tumor Cell Diagnostics Production Sites, Area Served, Product Types
- 2.5 Circulating Tumor Cell Diagnostics Market Competitive Situation and Trends
- 2.5.1 Circulating Tumor Cell Diagnostics Market Concentration Rate
- 2.5.2 Circulating Tumor Cell Diagnostics Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Circulating Tumor Cell Diagnostics Production Market Share by Regions
- 3.1 Global Circulating Tumor Cell Diagnostics Production Market Share by Regions
- 3.2 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Regions (2014-2019)
- 3.3 Global Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Circulating Tumor Cell Diagnostics Production
- 3.4.1 North America Circulating Tumor Cell Diagnostics Production Growth Rate (2014-2019)
- 3.4.2 North America Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Circulating Tumor Cell Diagnostics Production
- 3.5.1 Europe Circulating Tumor Cell Diagnostics Production Growth Rate (2014-2019)
- 3.5.2 Europe Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Circulating Tumor Cell Diagnostics Production (2014-2019)
- 3.6.1 China Circulating Tumor Cell Diagnostics Production Growth Rate (2014-2019)
- 3.6.2 China Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Circulating Tumor Cell Diagnostics Production (2014-2019)
- 3.7.1 Japan Circulating Tumor Cell Diagnostics Production Growth Rate (2014-2019)
- 3.7.2 Japan Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Circulating Tumor Cell Diagnostics Consumption by Regions
- 4.1 Global Circulating Tumor Cell Diagnostics Consumption by Regions
- 4.2 North America Circulating Tumor Cell Diagnostics Consumption (2014-2019)
- 4.3 Europe Circulating Tumor Cell Diagnostics Consumption (2014-2019)
- 4.4 China Circulating Tumor Cell Diagnostics Consumption (2014-2019)
- 4.5 Japan Circulating Tumor Cell Diagnostics Consumption (2014-2019)
5 Global Circulating Tumor Cell Diagnostics Production, Revenue, Price Trend by Type
- 5.1 Global Circulating Tumor Cell Diagnostics Production Market Share by Type (2014-2019)
- 5.2 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Type (2014-2019)
- 5.3 Global Circulating Tumor Cell Diagnostics Price by Type (2014-2019)
- 5.4 Global Circulating Tumor Cell Diagnostics Production Growth by Type (2014-2019)
6 Global Circulating Tumor Cell Diagnostics Market Analysis by Applications
- 6.1 Global Circulating Tumor Cell Diagnostics Consumption Market Share by Application (2014-2019)
- 6.2 Global Circulating Tumor Cell Diagnostics Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Circulating Tumor Cell Diagnostics Business
- 7.1 Janssen Diagnostics
- 7.1.1 Janssen Diagnostics Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 7.1.2 Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification
- 7.1.3 Janssen Diagnostics Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Advanced Cell Diagnostics
- 7.2.1 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 7.2.2 Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification
- 7.2.3 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Aviva Biosciences
- 7.3.1 Aviva Biosciences Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 7.3.2 Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification
- 7.3.3 Aviva Biosciences Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Biocept Inc
- 7.4.1 Biocept Inc Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 7.4.2 Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification
- 7.4.3 Biocept Inc Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Biofluidica Inc.
- 7.5.1 Biofluidica Inc. Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 7.5.2 Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification
- 7.5.3 Biofluidica Inc. Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 CellTraffix Inc.
- 7.6.1 CellTraffix Inc. Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 7.6.2 Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification
- 7.6.3 CellTraffix Inc. Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Clearbridge BioMedics Pte Ltd
- 7.7.1 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 7.7.2 Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification
- 7.7.3 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Epic Sciences Inc.
- 7.8.1 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 7.8.2 Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification
- 7.8.3 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Fluxion Biosciences Inc.
- 7.9.1 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 7.9.2 Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification
- 7.9.3 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 ScreenCell
- 7.10.1 ScreenCell Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 7.10.2 Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification
- 7.10.3 ScreenCell Circulating Tumor Cell Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 Silicon Biosystems
- 7.12 Sysmex Corporation
- 7.13 Greiner Bio-One GmbH
- 7.14 AdnaGen AG
- 7.15 Apocell Inc
- 7.16 Biocep Ltd
- 7.17 Canopus Bioscience Ltd
- 7.18 Creatv Microtech Inc
- 7.19 Ikonisys Inc
- 7.20 IV Diagnostics Inc
- 7.21 Miltenyi Biotech GmbH
- 7.22 Nanostring Technologies Inc
- 7.23 Rarecells Diagnostics.
- 7.24 Vitatex Inc
8 Circulating Tumor Cell Diagnostics Manufacturing Cost Analysis
- 8.1 Circulating Tumor Cell Diagnostics Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Circulating Tumor Cell Diagnostics
- 8.4 Circulating Tumor Cell Diagnostics Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Circulating Tumor Cell Diagnostics Distributors List
- 9.3 Circulating Tumor Cell Diagnostics Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Circulating Tumor Cell Diagnostics Market Forecast
- 11.1 Global Circulating Tumor Cell Diagnostics Production, Revenue Forecast
- 11.1.1 Global Circulating Tumor Cell Diagnostics Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Circulating Tumor Cell Diagnostics Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Circulating Tumor Cell Diagnostics Price and Trend Forecast (2019-2025)
- 11.2 Global Circulating Tumor Cell Diagnostics Production Forecast by Regions (2019-2025)
- 11.2.1 North America Circulating Tumor Cell Diagnostics Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Circulating Tumor Cell Diagnostics Production, Revenue Forecast (2019-2025)
- 11.2.3 China Circulating Tumor Cell Diagnostics Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Circulating Tumor Cell Diagnostics Production, Revenue Forecast (2019-2025)
- 11.3 Global Circulating Tumor Cell Diagnostics Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Circulating Tumor Cell Diagnostics Consumption Forecast (2019-2025)
- 11.3.2 Europe Circulating Tumor Cell Diagnostics Consumption Forecast (2019-2025)
- 11.3.3 China Circulating Tumor Cell Diagnostics Consumption Forecast (2019-2025)
- 11.3.4 Japan Circulating Tumor Cell Diagnostics Consumption Forecast (2019-2025)
- 11.4 Global Circulating Tumor Cell Diagnostics Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Circulating Tumor Cell Diagnostics Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Circulating Tumor Cell Diagnostics . Industry analysis & Market Report on Circulating Tumor Cell Diagnostics is a syndicated market report, published as Global Circulating Tumor Cell Diagnostics Market Research Report 2019. It is complete Research Study and Industry Analysis of Circulating Tumor Cell Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
